Find verified Ubrogepant API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Ubrogepant for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Ubrogepant API.
Alternate Names: Ubrelvy, MK-1602, AD0O8X2QJR, DTXSID00160178
CAS No: 1374248-77-7
Mol Formula: C29H26F3N5O3
Mol Weight: 549.5 g/mol
IUPAC Name: (3S)-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]p -Show More
API Description: Ubrogepant is an orally available, small molecule inhibitor of the calcitonin gene-related peptide (CGRP) receptor that blocks the action of CGRP, a potent vasodilator believed to play a role in migraine headaches. Ubrogepant is approved for treatment of acute migraine attacks. In clinical trials, urbrogepant was generally well tolerated with only rare instances of transient serum aminotransferase elevations during therapy and with no reported instances of clinically apparent liver injury.
